Alyeska Investment Group, L.P. Seagen Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $9.88 Million - $16.3 Million	-90,824 Reduced 38.01%	148,149 $26.2 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $14.1 Million - $18.5 Million	117,483 Added 96.7%	238,973 $34.4 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $15.1 Million - $20.1 Million	-105,570 Reduced 46.49%	121,490 $18.8 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $13.6 Million - $16.2 Million	95,244 Added 72.26%	227,060 $38.6 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $17.8 Million - $21.2 Million	131,816 New	131,816 $20.8 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.